Benzinga's Top Initiations - Autoliv (NYSE:ALV), Aclaris Therapeutics (NASDAQ:ACRS)

Analysts at Jefferies initiated coverage on Autoliv Inc. ALV with a Buy rating. The price target for Autoliv is set to $112. Autoliv shares closed at $102.92 on Monday.
Analysts at Credit Suisse initiated coverage on Royal Bank of Scotland Group PLC RBS with an Underperform rating. Royal Bank of Scotland shares closed at $4.82 on Monday.
Analysts at Leerink initiated coverage of Aclaris Therapeutics Inc ACRS with an Outperform rating. The price target for Aclaris Therapeutics is set to $54. Aclaris Therapeutics shares closed at $28.04 on Monday.
Analysts at Aegis Capital initiated coverage on Revance Therapeutics Inc RVNC with a Buy rating. The price target for Revance Therapeutics is set to $28. Revance Therapeutics shares closed at $17.60 on Monday.
Benchmark initiated coverage on Heska Corp HSKA with a Buy rating. The price target for Heska is set to $78. Heska shares closed at $65.60 on Monday.
Analysts at Oppenheimer initiated coverage on Celgene Corporation CELG with an Outperform rating. The price target for Celgene is set to $141. Celgene shares closed at $120.30 on Monday.
Analysts at Credit Suisse initiated coverage on Smart Sand Inc SND with an Outperform rating. The price target for Smart Sand is set to $14. Smart Sand shares closed at $12.39 on Monday.
Analysts at HSBC initiated coverage on Air Products & Chemicals, Inc. APD with a Hold rating. The price target for Air Products is set to $140. Air Products shares closed at $141.78 on Monday.
Atlantic Equities initiated coverage on Sherwin-Williams Co SHW with an Overweight rating. Sherwin-Williams shares closed at $274.02 on Monday.
Wells Fargo initiated coverage on Chesapeake Utilities Corporation CPK with a Market Perform rating. Chesapeake Utilities shares closed at $67.25 on Monday.

Market News and Data brought to you by Benzinga APIs